CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Overview Fund Activity
Delisted

CPXX was delisted on the 11th of July, 2016.

Back to rankings

14 hedge funds and large institutions have $5.34M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
6
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SIM
1
Spark Investment Management
New York
$80K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$481K
3
TRCT
3
Tower Research Capital (TRC)
New York
$7K
4
Deutsche Bank
4
Deutsche Bank
Germany
$4K
5
NPC
5
National Planning Corporation
California
$2.14K

Top Sellers

1
OM
1
Opaleye Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CC
1
Caxton Corporation
New Jersey
$4.4M 2,246,469 – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$481K 245,543 +21,176 +9%
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$253K 87,900 – –
SIM
4
Spark Investment Management
New York
$80K 41,500 +21,600 +109%
ACI
5
Alpha Cubed Investments
California
$63K 32,092 – –
CPA
6
Cowen Prime Advisors
New York
$38K 19,250 – –
TRCT
7
Tower Research Capital (TRC)
New York
$7K 3,385 +3,385 New
BIM
8
BlackRock Investment Management
Delaware
$6K 3,308 +443 +15%
Deutsche Bank
9
Deutsche Bank
Germany
$4K 2,300 +2,300 New
Bank of America
10
Bank of America
North Carolina
$3K 1,704 – –
MA
11
MUFG Americas
New York
$3K 1,540 +550 +56%
NPC
12
National Planning Corporation
California
$2.14K 1,000 +1,000 New
SM
13
Sabby Management
Florida
$275 140,234 +33,105 +31%
OM
14
Opaleye Management
Massachusetts
– – -405,000 Closed
Morgan Stanley
15
Morgan Stanley
New York
$0 57 +13 +30%